WallStreetZenWallStreetZen

NASDAQ: SHLT
Shl Telemedicine Ltd Stock

$6.15+0.00 (+0%)
Updated Mar 1, 2024
SHLT Price
$6.15
Fair Value Price
$8.41
Market Cap
$100.78M
52 Week Low
$5.67
52 Week High
$51.81
P/E
-41x
P/B
1.32x
P/S
2.87x
PEG
N/A
Dividend Yield
N/A
Revenue
$57.10M
Earnings
-$2.32M
Gross Margin
43.9%
Operating Margin
3.27%
Profit Margin
-4.1%
Debt to Equity
0.53
Operating Cash Flow
-$5M
Beta
-0.31
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

SHLT Overview

SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. The company offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; Cardio'B, a portable device to transmit a 12-lead ECG; and Cardio Beeper 12/12, a hand-held ECG transmitter device for personal use that transmits a full ECG reading to the monitoring center. It also provides central communication module, a telecommunication device that transmits medical data to its telemedicine centers from various medical monitoring devices; TeleWeight, a trans-telephonic weight monitoring device for personal use; TelePress, a remote blood pressure monitoring device for personal use; TeleBreather, a remote electronic handheld device to test the working of lungs; and TelePulse Oximeter, an electronic handheld diagnostic device to measure the saturation level of oxygen in blood, as well as pulse rate. The company offers its telemedicine services and devices to subscribers using telephonic and internet communication technology. It serves patients, health insurance companies, hospitals, clinics, physicians, and other health care providers. The company has a collaboration agreement with Mayo Clinic to evaluate the incidence of emergency department visits, re-hospitalizations, and major adverse cardiovascular events over a period of 90 days after first hospitalization for a heart attack for patients using SmartHeart FDA approved 12 lead ECG; and collaboration agreement with the Hebrew University of Jerusalem and the Hadassah Medical Center to develop an artificial intelligence tool for predicting future life-threatening cardiac events based on 12 Lead ECG monitoring. SHL Telemedicine Ltd. was founded in 1987 and is headquartered in Tel Aviv, Israel.

Zen Score

Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SHLT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

SHLT ($6.15) is undervalued by 26.9% relative to our estimate of its Fair Value price of $8.41 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
SHLT ($6.15) is significantly undervalued by 26.9% relative to our estimate of its Fair Value price of $8.41 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
SHLT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more SHLT due diligence checks available for Premium users.

Be the first to know about important SHLT news, forecast changes, insider trades & much more!

SHLT News

Valuation

SHLT fair value

Fair Value of SHLT stock based on Discounted Cash Flow (DCF)
Price
$6.15
Fair Value
$8.41
Undervalued by
26.90%
SHLT ($6.15) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
SHLT ($6.15) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
SHLT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

SHLT price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-41x
Industry
88.3x
Market
36.17x

SHLT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.32x
Industry
3.69x
SHLT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

SHLT's financial health

Profit margin

Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
SHLT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
SHLT's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$119.8M
Liabilities
$40.2M
Debt to equity
0.53
SHLT's short-term assets ($44.40M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SHLT's short-term assets ($44.40M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SHLT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
N/A
Investing
N/A
Financing
N/A
SHLT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

SHLT vs Health Information Service Stocks

TickerMarket Cap1d %P/EP/B
SHLT$100.78M0.00%-41.00x1.32x
SY$109.30M-3.48%24.13x0.33x
FORA$88.59M-1.38%15.05x3.32x
NUTX$75.80M0.00%-3.77x0.84x
CPSI$133.70M+3.72%-153.17x0.59x

Shl Telemedicine Stock FAQ

What is Shl Telemedicine's quote symbol?

(NASDAQ: SHLT) Shl Telemedicine trades on the NASDAQ under the ticker symbol SHLT. Shl Telemedicine stock quotes can also be displayed as NASDAQ: SHLT.

If you're new to stock investing, here's how to buy Shl Telemedicine stock.

What is the 52 week high and low for Shl Telemedicine (NASDAQ: SHLT)?

(NASDAQ: SHLT) Shl Telemedicine's 52-week high was $51.81, and its 52-week low was $5.67. It is currently -88.13% from its 52-week high and 8.47% from its 52-week low.

How much is Shl Telemedicine's stock price per share?

(NASDAQ: SHLT) Shl Telemedicine stock price per share is $6.15 today (as of Mar 1, 2024).

What is Shl Telemedicine's Market Cap?

(NASDAQ: SHLT) Shl Telemedicine's market cap is $100.78M, as of Mar 3, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Shl Telemedicine's market cap is calculated by multiplying SHLT's current stock price of $6.15 by SHLT's total outstanding shares of 16,386,180.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.